As India and the Philippines celebrated 75 years of diplomatic relations, the Ministry of External Affairs (MEA) unveiled a ...

ANI Pharmaceuticals (ANIP – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Oren ...

Truist Financial analyst Les Sulewski maintained a Hold rating on ANI Pharmaceuticals (ANIP – Research Report) today and set a price target of $62.00. The company’s shares closed last Friday at $61.44 ...

Q3 2024 Earnings Call Transcript November 8, 2024 ANI Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.34, expectations were $1.09. Operator: Good day, everyone, and welcome to ...

ANIP may be acquired soon with a potential offer exceeding $8 billion and contingent on FDA approval of a new drug filed in ...

ANI Pharmaceuticals ranks in the middle for consensus rating among its peers. It is at the bottom for revenue growth. In terms of gross profit, it is at the top among its peers. However, for return on ...

Update 2:40pm: Adds ANI Pharma response, updates shares. Alimera Sciences (NASDAQ:ALIM) pared an earlier drop to 6% after it said it filed a lawsuit against ANI Pharmaceuticals (ANIP) to compel ...

BAUDETTE, Minn. (AP) — BAUDETTE, Minn. (AP) — ANI Pharmaceuticals Inc. (ANIP) on Friday reported a third-quarter loss of $24.2 million, after reporting a profit in the same period a year earlier. The ...

(RTTNews) - While reporting financial results for the third quarter on Friday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) raised its adjusted earnings and net revenue guidance for ...

Earlier this year, ANI Pharmaceuticals acquired Alimera Sciences for $5.50 per share in cash and one non-tradable contingent value right (CVR) of up to $0.50 per share upon achieving certain net ...

ANI Pharmaceuticals (NASDAQ:ANIP) is preparing to release its quarterly earnings on Friday, 2024-11-08. Here's a brief overview of what investors should keep in mind before the announcement.